BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23073742)

  • 1. Fat necrosis and parenchymal scarring after breast-conserving surgery and radiotherapy with an intraoperative electron or fractionated, percutaneous boost: a retrospective comparison.
    Piroth MD; Fischedick K; Wein B; Heindrichs U; Piroth DM; Holy R; Pinkawa M; Eble MJ
    Breast Cancer; 2014 Jul; 21(4):409-14. PubMed ID: 23073742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
    Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
    Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early mammographic and sonographic findings after intraoperative radiotherapy (IORT) as a boost in patients with breast cancer.
    Wasser K; Schoeber C; Kraus-Tiefenbacher U; Bauer L; Brade J; Teubner J; Wenz F; Neff W
    Eur Radiol; 2007 Jul; 17(7):1865-74. PubMed ID: 17237946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
    Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis.
    Fastner G; Sedlmayer F; Merz F; Deutschmann H; Reitsamer R; Menzel C; Stierle C; Farmini A; Fischer T; Ciabattoni A; Mirri A; Hager E; Reinartz G; Lemanski C; Orecchia R; Valentini V
    Radiother Oncol; 2013 Aug; 108(2):279-86. PubMed ID: 23830467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
    Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B
    Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.
    Fastner G; Hauser-Kronberger C; Moder A; Reitsamer R; Zehentmayr F; Kopp P; Fussl C; Fischer T; Deutschmann H; Sedlmayer F
    Strahlenther Onkol; 2016 Jan; 192(1):1-7. PubMed ID: 26403912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up-findings in mammography and ultrasound after intraoperative radiotherapy (IORT) for breast cancer.
    Ruch M; Brade J; Schoeber C; Kraus-Tiefenbacher U; Schnitzer A; Engel D; Wenz F; Sütterlin M; Schoenberg SO; Wasser K
    Breast; 2009 Oct; 18(5):327-34. PubMed ID: 19909898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
    Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma.
    Gultekin M; Yazici O; Eren G; Yuce D; Aksoy S; Ozisik Y; Guler N; Yazici G; Hurmuz P; Yildiz F; Altundag K; Gurkaynak M
    Breast; 2014 Dec; 23(6):775-83. PubMed ID: 25201554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
    Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
    Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
    Freeman AB; Huang B; Dragun AE
    Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence patterns in breast cancer patients treated with oncoplastic reduction mammaplasty and radiotherapy.
    Eaton BR; Losken A; Okwan-Duodu D; Schuster DM; Switchenko JM; Mister D; Godette K; Torres MA
    Ann Surg Oncol; 2014 Jan; 21(1):93-9. PubMed ID: 24081796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer.
    Ott OJ; Schulz-Wendtland R; Uter W; Pfahlberg A; Beckmann MW; Sauer R; Strnad V
    Strahlenther Onkol; 2005 Oct; 181(10):638-44. PubMed ID: 16220402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer.
    Wong WW; Pockaj BA; Vora SA; Halyard MY; Gray RJ; Schild SE
    Breast J; 2014; 20(2):125-30. PubMed ID: 24372873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.